Current insights on biomarkers in lupus nephritis: a systematic review of the literature
Lupus nephritis (LN) is a major cause of morbidity and mortality among patients with
systemic lupus erythematosus (SLE). However, promising emerging biomarkers pave the …
systemic lupus erythematosus (SLE). However, promising emerging biomarkers pave the …
Ceramides in autoimmune rheumatic diseases: existing evidence and therapeutic considerations for diet as an anticeramide treatment
I Alexandropoulou, MG Grammatikopoulou… - Nutrients, 2023 - mdpi.com
Autoimmune rheumatic diseases (AIRDs) constitute a set of connective tissue disorders and
dysfunctions with akin clinical manifestations and autoantibody responses. AIRD treatment …
dysfunctions with akin clinical manifestations and autoantibody responses. AIRD treatment …
Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations
R Watanabe, M Hashimoto - Journal of Clinical Medicine, 2023 - mdpi.com
Eosinophilic granulomatosis with polyangiitis (EGPA) causes necrotizing vasculitis and
eosinophil-rich granulomatous inflammation in small-to medium-sized vessels, resulting in …
eosinophil-rich granulomatous inflammation in small-to medium-sized vessels, resulting in …
Diagnostic and therapeutic approach in ANCA-associated glomerulonephritis: a review on management strategies
A Molnár, P Studinger, N Ledó - Frontiers in Medicine, 2022 - frontiersin.org
Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis is a destructive small
vessel vasculitis affecting multiple organs. Renal involvement often leads to end-stage renal …
vessel vasculitis affecting multiple organs. Renal involvement often leads to end-stage renal …
Biologics for eosinophilic granulomatosis with polyangiitis
M Caminati, M Maule, F Bello… - Current opinion in allergy …, 2023 - journals.lww.com
Taking into account the suboptimal medium-long term safety profile of conventional EGPA
treatments, the opportunity of selectively targeting eosinophilic inflammation certainly …
treatments, the opportunity of selectively targeting eosinophilic inflammation certainly …
Salivary gland involvement in ANCA-associated vasculitis
M Akiyama, S Takanashi, T Takeuchi, Y Kaneko - Autoimmunity Reviews, 2021 - Elsevier
Objective Salivary gland involvement in anti-neutrophil cytoplasmic autoantibody (ANCA)-
associated vasculitis is rare, but can lead to the misdiagnosis of other diseases. The …
associated vasculitis is rare, but can lead to the misdiagnosis of other diseases. The …
The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies
A Walulik, K Łysak, M Błaszkiewicz, I Górecki… - International Journal of …, 2023 - mdpi.com
Recent years have brought progress in understanding the role of the neutrophil, dispelling
the dogma of homogeneous cells mainly involved in the prime defence against pathogens …
the dogma of homogeneous cells mainly involved in the prime defence against pathogens …
The eye is a common site of granulomatosis with polyangiitis. A collaborative study
R Dammacco, J Biswas, A Mohanan-Earatt, W Lisch… - BMC …, 2023 - Springer
Background Ocular manifestations of granulomatosis with polyangiitis (GPA) have been
reported in a limited number of studies and with largely variable frequency. Here we report …
reported in a limited number of studies and with largely variable frequency. Here we report …
Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models
M Alipour, M Tebianian, N Tofigh, RS Taheri… - Neuropeptides, 2022 - Elsevier
Traumatic brain injury (TBI), characterized by acute neurological impairment, is associated
with a higher incidence of neurodegenerative diseases, particularly chronic traumatic …
with a higher incidence of neurodegenerative diseases, particularly chronic traumatic …
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives
L Quartuccio, E Treppo, L Urso, G Del Frate… - Frontiers in …, 2023 - frontiersin.org
In recent years, clinical research has increased significantly and therapies for antineutrophil
cytoplasmic antibody (ANCA)-associated vasculitis have improved. However, there are still …
cytoplasmic antibody (ANCA)-associated vasculitis have improved. However, there are still …